Latest Production News

Australian Dairy Nutritionals Limited reports improved cash flow in Q2 FY25 and prepares for the strategic launch of its premium Future brand in China, aiming to reshape its growth trajectory.

Telix Pharmaceuticals has completed a strategic acquisition of ImaginAb, gaining next-generation therapeutic assets and a novel biologics platform to expand its oncology pipeline and R&D capabilities.

Mach7 Technologies reports a robust Q2 FY25 with a 15.6% increase in Contracted Annual Recurring Revenue, reaffirming its FY25 growth guidance and initiating a $5 million share buy-back.

Vintage Energy Ltd has launched a $2.1 million entitlement offer, issuing 417.3 million new shares and free attaching options to fund a production uplift program targeting scale accumulation in its Southern Flank gas fields.

Brookside Energy Ltd delivered a standout quarter in Q4 2024, posting record production growth and a 667% jump in operating cash flow, while completing a major development project ahead of schedule and under budget.

Vintage Energy has launched a $2.1 million entitlement offer to fund a targeted production uplift program at its Odin and Vali gas fields, aiming to significantly increase gas output and cash flow in the near term.

Canterbury Resources reports significant drilling success at its Briggs copper-molybdenum project, with an updated resource estimate and scoping study underway, while exploration at Bismarck yields no economic mineralisation.

QMines Limited has completed a significant drilling campaign at its newly acquired Develin Creek copper project, delivering promising assay results that reinforce the project's potential to expand the Mt Chalmers mine plan.

Vintage Energy reported a 105% jump in quarterly sales revenue driven by a 90% increase in production, despite operational challenges at its Odin-2 well and the termination of a merger proposal with Galilee Energy.

PainChek Ltd reports robust growth with 100,000 contracted licences globally and positive FDA clearance progress, alongside a promising launch of its Infant App targeting a vast new market.

ImpediMed Limited has reported record quarterly revenue and cash receipts for Q2 FY25, alongside significant growth in reimbursement coverage and a robust sales pipeline, signaling strong momentum in its digital health platform business.

Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.